CMTA has committed $206,000 over three years to support the Inherited Neuropathy Consortium (INC) in advancing CMT research. Since September 2022, this funding has sustained 20 clinical sites, supported over 20 scientific publications, and enabled large-scale natural history studies of CMT1B and CMT1X. With more than 7,000 patients enrolled, INC’s data set is critical for future clinical trials and Investigational New Drug (IND) approvals.
Simply CMT
More From Simply CMT
-
Bringing Home The Magic of Camp Footprint
The Footprint Fellowship helps campers with CMT carry the confidence, connection, and authenticity they find at Camp Footprint into their everyday lives.
-
CMTA Camp Footprint Launches Fellowship with ACA Grant
A new year-long program helps campers bring the confidence of camp home